Literature DB >> 27742653

Cancer-related financial toxicity: beyond the realm of drug pricing and out-of-pocket costs.

S F Huntington1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27742653     DOI： 10.1093/annonc/mdw540

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Cancer cost communication: experiences and preferences of patients, caregivers, and oncologists-a nationwide triad study.

Authors:  So Young Kim; Dong Wook Shin; Boyoung Park; Juhee Cho; Jae Hwan Oh; Sun Seog Kweon; Hye Sook Han; Hyung Kook Yang; Keeho Park; Jong-Hyock Park
Journal:  Support Care Cancer       Date:  2018-04-25       Impact factor: 3.603

2.  Temporal and geographic variation in the systemic treatment of advanced prostate cancer.

Authors:  Megan E V Caram; Jason P Estes; Jennifer J Griggs; Paul Lin; Bhramar Mukherjee
Journal:  BMC Cancer       Date:  2018-03-06       Impact factor: 4.430

3.  Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.

Authors:  J Witte; K Mehlis; B Surmann; R Lingnau; O Damm; W Greiner; E C Winkler
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

4.  The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.

Authors:  Katja Mehlis; Julian Witte; Bastian Surmann; Matthias Kudlich; Leonidas Apostolidis; Jürgen Walther; Dirk Jäger; Wolfgang Greiner; Eva C Winkler
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

5.  Multiple myeloma, race, insurance and treatment.

Authors:  Himanshu Joshi; Sylvia Lin; Kezhen Fei; Anne S Renteria; Hannah Jacobs; Madhu Mazumdar; Sundar Jagannath; Nina A Bickell
Journal:  Cancer Epidemiol       Date:  2021-07-06       Impact factor: 2.890
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.